Boston, MA 05/27/2014 (wallstreetpr) – Zoetis Inc (NYSE:ZTS) is almost 60 years old animal health business. The company holds a dignified position in the discovery and production of animal medicines and vaccines. The company has announced to participate in the ‘William Blair 34th Annual Growth Stock Conference.’
Zoetis to present in the William Blair conference:
According to the news published on May 23, 2014, the animal health company will take part in the “William Blair 34th Annual Growth Stock Conference”. Zoetis Inc (NYSE:ZTS) will participate in the conference on Thursday, June 12, 2014. The Chief Executive Officer of the company, Juan Ramos Alaix will be in the conference as the representative of Zoetis in Chicago. The CEO has been scheduled to deliver his presentation at 9:40 am.
Pfizer offering a share exchange:
On the same day another dramatic news was published, which states that the leading drug manufacturing company Pfizer is offering a share exchange to the investors to reduce 80.2% of the stake in Zoetis. The animal health company was spun off about 4 months ago.
According to this new offering, the shareholders of Pfizer Inc (NYSE:PFE) will have the choice to swap their shares for Zoetis. The leading drug maker made this announcement that clearly indicates the mode of tax free transaction.
The strategy of Pfizer’s CEO:
The New Jersey based Zoetis Inc (NYSE:ZTS) will be fully independent if the exchange is completely subscribed. The exchange will somehow result in an end the plan of the Chief Executive Officer of Pfizer. The CEO, Ian Read, planned to downsize the company and at the same time concentrate on the production of new drugs. The shares of Zoetis increased 29% since February, after the trading started.
Zoetis Inc (NYSE:ZTS) earned annual revenue of $4.6 billion in 2013. The animal medicine and vaccine’s manufacturing company host its business across 70 countries. However, it is time to see how the company reciprocates the challenge this year!
